See other bills
under the
same topic
PRINTER'S NO. 4106
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
937
Session of
2020
INTRODUCED BY SCHLEGEL CULVER, HENNESSEY, SONNEY, MILLARD,
SCHMITT, KINSEY, MURT, RYAN, BROWN, KORTZ, MEHAFFIE, BURNS,
PICKETT, LONGIETTI, READSHAW, GREEN, MOUL AND NEILSON,
JULY 8, 2020
REFERRED TO COMMITTEE ON HEALTH, JULY 8, 2020
A RESOLUTION
Recognizing the month of September 2020 as "Histiocytosis
Awareness Month" in Pennsylvania.
WHEREAS, Histiocytosis is a general name for a group of rare
disorders that involve an abnormal increase in the number of
specialized white blood cells that are called histiocytes; and
WHEREAS, In 1987, the Histiocyte Society first classified
this group of disorders into three categories; and
WHEREAS, The first category, dendritic cell disorder,
includes Langerhans cell histosis, juvenile xanthogranuloma and
Erdheim-Chester disease; and
WHEREAS, The second category, macrophage cell disorder,
includes hemophagocytic lymphohistiocytosis and Rosai-Dorfman
disease; and
WHEREAS, The third category, malignant histiocytosis,
includes certain kinds of leukemia and malignant tumors; and
WHEREAS, There are multiple competing classification systems,
including a proposed five-category system; and
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
WHEREAS, Chemotherapy is a common treatment for histiocytosic
disorders; and
WHEREAS, Histiocytosic disorders can affect children or
adults, and more research is needed to help those impacted by
the disorders; therefore be it
RESOLVED, That the House of Representatives recognize the
month of September 2020 as "Histiocytosis Awareness Month" in
Pennsylvania.
20200HR0937PN4106 - 2 -
1
2
3
4
5
6
7
8